Rockefeller Capital Management L.P. Glaukos Corp Transaction History

Rockefeller Capital Management L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$46.84 - $58.49 $15,269 - $19,067	-326 Reduced 98.19%	6 $0
Q2 2022 Aug 12, 2022	BUY	$34.86 - $63.77 $2,579 - $4,718	74 Added 28.68%	332 $15,000
Q1 2022 May 13, 2022	BUY	$44.33 - $57.82 $6,782 - $8,846	153 Added 145.71%	258 $14,000
Q3 2021 Nov 12, 2021	BUY	$47.43 - $84.23 $47 - $84	1 Added 0.96%	105 $5,000
Q2 2021 Aug 10, 2021	BUY	$73.06 - $97.7 $7,598 - $10,160	104 New	104 $8,000
Q1 2021 May 11, 2021	SELL	$70.43 - $97.42 $1,338 - $1,850	-19 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$48.9 - $75.26 $929 - $1,429	19 New	19 $1,000
Q3 2020 Nov 13, 2020	SELL	$37.23 - $50.97 $1,638 - $2,242	-44 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$28.78 - $46.83 $3,079 - $5,010	-107 Reduced 70.86%	44 $2,000
Q1 2020 May 12, 2020	BUY	$25.53 - $70.14 $1,302 - $3,577	51 Added 51.0%	151 $5,000
Q1 2019 May 10, 2019	BUY	$50.75 - $80.54 $5,075 - $8,054	100 New	100 $8,000

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.